Abstract
Background
The use of adjunct antimetabolite therapy along with conjunctiva autograft has been shown to be effective in preventing pterygium recurrence. There has however been fewer reports on the effect of anti-vascular endothelial growth factor on pterygium recurrence.
Objective
To compare 5-fluorouracil with conjunctival autograft with bevacizumab (avastin) used along with autograft in the surgical treatment of pterygium.
Methods
A randomized controlled prospective study of outcome of pterygium treatment using 5-fluorouracil with conjunctiva autograft as adjuvant treatment compared avastin with conjunctiva autograft.
Results
A total of 70 eyes of 70 patients were recruited into the study with a mean age of 51.49 (±14.36) years. Thirty-five patients each were randomized into the 5-fluorouracil treatment group and into the avastin treatment group respectively. The mean follow-up was 18.35 months (18.44 for the 5-FU and 18.26 for the avastin group). Post operative, pterygium recurrence was observed in 1/27 (3.7%) eyes treated with 5-fluorouracil and 1/26 (3.9%) eyes of the avastin group. Both recurrences were observed at 1 year of follow-up and they were both female patients aged 46 and 52 years, respectively.
Conclusions
Both 5-fluorouracil and avastin are comparably effective as adjunct to conjunctival autograft. However, cost, availability, and convenience are other considerations with use of avastin.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Moran DJ, Hollows FC . Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol 1984; 68: 343–346.
Taylor HR, West S, Munoz B . The long-term effects of visible light on the eye. Arch Ophthalmol 1992; 110: 99–104.
Cameron ME . Pterygium throughout the world. Charles C. Thomas: Springfield, Illinois, USA, 1965.
D’ Ombrain A . The surgical treatment of pterygium. Br J Ophthalmol 1948; 32: 65–71.
Youngson RM . Recurrence of pterygium after excision. Br J Ophthalmol 1972; 56: 120–125.
Kutbaab A, Ardekani HA, Khoshniyat H, Hosseini HJ . Amniotic membrane transplantation for primary pterygium surgery. J Ophthalmic Vis Res 2008; 3 (1): 23–27.
Figueira EC, Coroneo MT, Francis IC . Preventing conjunctival autograft inversion in pterygium surgery. Br J Ophthalmol 2007; 91: 83–84.
Kenyon KR, Wagoner MD, Hettinger ME . Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985; 92: 1461–1470.
McCoombes JA, Hirst LW, Isbell GP . Sliding conjunctival flap for the treatment of primary pterygium. Ophthalmology 1994; 101: 169–173.
Ajayi BG, Bekibele CO . Evaluation of the effectiveness of postoperative beta irradiation in the management of pterygium. Afr J Med Med Sci 2002; 31: 9–11.
Jurgenliemk-Schulz IM, Hartman IJ, Roesink JM, Tersteeg RJ, Van der Tweel I, Kal HB et al. Prevention of pterygium recurrence by postoperative single dose beta irradiation: A prospective randomized clinical double blind trial. Int J Radiat Oncol Biol Phys 2004; 59: 1138–1147.
Smith S, D’Amore PA, Dreyer EB . Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 1994; 118: 332–337.
Chen KH, Hsu WM . Intraoperative ethanol treatment as an adjuvant therapy of pterygium excision. Int J Biomed Sci 2006; 2: 414–421.
Detorakis ET, Zaravinos A, Spandidos DA . Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med 2010; 25: 513–516.
Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 2011; 29: 142–148.
Stinchcombe TE, Socinski MA . Maintenance therapy in advanced non-small cell lung cancer: current status and future implications. J Thorac Oncol 2011; 6: 174–182.
Barrena Medel NI, Herzog TJ, Wright JD, Lewin SN . Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report. Anticancer Res 2010; 30: 4767–4768.
Fojo T, Wilkerson J . Bevacizumab and breast cancer: the E2100 outlier. Lancet Oncol 2010; 11: 1117–1119.
Waisbourd M, Goldstein M, Loewenstein A . Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol 2011; 89: 203–207.
Figueroa MS, Contreras I, Noval S, Arruabarrena C . Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol 2010; 94: 1052–1056.
Schouten JS, La Heij EC, Webers CA, Lundqvist IJ, Hendrikse F . A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1.
Habot-Wilner Z, Barequet IS, Ivanir Y, Moisseiev J, Rosner M . The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization. Acta Ophthalmol 2010; 88: 862–867.
Nava-Castañeda A, Olvera-Morales O, Ramos-Castellon C, Garnica-Hayashi L, Garfias Y . Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up. Clin Experiment Ophthalmol 2014; 42: 235–241.
Mohammad-Reza R, Mohammad B . Subconjunctival bevacizumab for primary pterygium excision, a randomized clinical trial. J Ophthalmic Vis Res 2014; 9 (1): 22–30.
Bekibele CO, Baiyeroju AM, Olusanya BA, Ashaye AO, Oluleye TS . Pterygium treatment using 5-FU as adjunct treatment compared to conjunctiva autograft. Eye 2008; 22: 31–34.
Kareem AA, Farhood QK, Alhammami HA . The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium. Clin Ophthalmol 2012; 6: 1849–1854.
Bekibele CO, Ashaye A, Olusanya B, Baiyeroju AM, Fasina O, Ibrahim AO et al. 5-Fluorouracil versus mitomycin C as adjunct to conjunctival autograft in preventing pterygium recurrence. Int Ophthalmol 2012; 32 (1): 3–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bekibele, C., Sarimiye, T., Ogundipe, A. et al. 5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium. Eye 30, 515–521 (2016). https://doi.org/10.1038/eye.2016.29
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2016.29
This article is cited by
-
Effect of multiple subconjunctival conbercept injections as an adjuvant to the surgical treatment of pterygium: a prospective randomised comparative 6-month follow-up study
Eye (2020)
-
Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis
BMC Ophthalmology (2017)
